SCRS Announces Site Scholarships
Ellicott City, MD – SCRS announces Site Scholarships sponsored by Total Clinical Trial Management (TCTM). TCTM recognizes the pivotal role SCRS provides in enhancing site success and ensuring their sustainability. These site scholarships will be awarded to site partners identified by TCTM that are not already members of SCRS.
“SCRS has reached over 3,000 research sites and welcomes this opportunity to support more sites in achieving their fullest potential,” said Christine Pierre, President of SCRS. “TCTM has taken a position of being site-centric and by providing these scholarships they are continuing to demonstrate their commitment to being a strong site partner.”
“TCTM is an enthusiastic supporter of SCRS and their mission, and we believe the clinical research ecosystem will be enhanced by enabling the involvement and supporting the membership of more research sites in SCRS,” commented Tim Evans, Vice President, Business Development at TCTM.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 3,000 research sites in 49 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit
About Total Clinical Trial Management
Total Clinical Trial Management (TCTM) is a boutique contract research organization based in Dallas, Texas. TCTM has a unique perspective on emphasizing the relationship with the clinical research site as a primary driver for successful clinical trial completion. Visit
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025